Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 19, 2022

SELL
$10.22 - $23.7 $2,657 - $6,162
-260 Reduced 92.86%
20 $0
Q2 2022

Jul 12, 2022

BUY
$4.35 - $15.85 $782 - $2,853
180 Added 180.0%
280 $3,000
Q1 2022

Apr 25, 2022

BUY
$4.55 - $6.41 $455 - $641
100 New
100 $0

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.